Graypoint LLC portfolio

Q2 2022 · Holdings as of · Filed · $779,504,000 reported in Form 13F

What changed in Q2 2022?

Comparable share positions since Q1 2022.

View all holdings
New
13
Increased
122
Reduced
129
Exited
34

Largest disclosed changes

  1. RPRX Reduced

    ROYALTY PHARMA PLC SHS CLASS A

    -481,673 shares

    -$20,247,228 estimated

    Weight -1.73 percentage points

  2. GVI Reduced

    ISHARES INTERMEDIATE GOVERNMENT/CREDIT BOND ETF

    -86,832 shares

    -$9,161,258 estimated

    Weight -0.9 percentage points

  3. LQDH Reduced

    ISHARES INTEREST RATE HEDGED CORPORATE BOND ETF

    -86,546 shares

    -$7,808,156 estimated

    Weight -0.78 percentage points

  4. LQD Reduced

    ISHARES IBOXX $ INVESTMENT GRADE CORPORATE BOND ETF

    -53,471 shares

    -$5,883,854 estimated

    Weight -0.54 percentage points

  5. VCSH Reduced

    VANGUARD SHORT-TERM CORPORATE BOND INDEX FUND

    -76,715 shares

    -$5,850,996 estimated

    Weight -0.49 percentage points

Estimates use share changes and filing prices. They are not trade proceeds. Options and principal positions are excluded.

Compare with Q1 2022

Holdings

Sym Weight Trade Impact Company Class Share Change Activity Value change SEC-reported value SEC-reported price Shares Principal
Filing details and SEC source
13F snapshot Latest parsed holdings, value, and filing-period context. 1 signal
What this filing covers

Period

Q2 2022

Calendar quarter covered by the filing.

13F holdings

295

Parsed equity rows, excluding option-only view rows.

Reported value

$779,504,000

SEC Form 13F market value, not total AUM.

Accepted by SEC

01 Aug 2022

EDGAR acceptance date.

How to read this filing
  • Start with the largest positions and changes, then open issuer-level rows for CUSIP-specific history.
  • Form 13F market value excludes cash and many non-13F assets, so it should not be treated as total assets under management.
  • SEC classifies this as a holdings report: this manager reports its visible U.S.-listed equity holdings in this filing.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
Steven Pardo - Compliance Officer
Manager location
Albany, NY
Source evidence Original filing metadata and source links for verification. 5 source fields
Accepted by SEC
01 Aug 2022, 15:38:52 UTC
SEC form
13F-HR
Prior SEC filing
Q1 2022 - 19 Apr 2022
Next SEC filing
Q3 2022 - 31 Oct 2022
Source filing
View source filing
This view compares filing 2022 Q2 with 2022 Q1. Changes are calculated against the previous SEC filing.
SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held.
* marks a reported price that did not pass the local price check.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Steven Pardo Compliance Officer Albany, New York 28 Jul 2022
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .